Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Updated: Oct 10, 2026
Do Kim's Stock Ratings
Piper Sandler Analyst
Do Kim is an analyst at Piper Sandler. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
3.01%
Smart Score
Overall Average Return Percentile
43rd
Number of Ratings
74
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/22/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $44.97 | 40.09% | $62 → $63 | Maintains | Overweight | Get Alert | |
| 01/18/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $44.97 | 37.87% | $60 → $62 | Maintains | Overweight | Get Alert | |
| 06/07/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $44.97 | 28.97% | → $58 | Assumes | → Overweight | Get Alert | |
| 02/21/2023 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -11.75% | $42 → $46 | Maintains | Overweight | Get Alert | |
| 02/08/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.08 | -41.97% | → $296 | Maintains | Neutral | Get Alert | |
| 02/03/2023 | GILD | Buy Now | Gilead Sciences | $151.20 | -25.93% | $111 → $112 | Maintains | Overweight | Get Alert | |
| 01/19/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.08 | -41.97% | $293 → $296 | Maintains | Neutral | Get Alert | |
| 01/19/2023 | SDGR | Buy Now | Schrodinger | $27.24 | 219.37% | $86 → $87 | Maintains | Overweight | Get Alert | |
| 01/19/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $44.97 | 37.87% | $60 → $62 | Maintains | Overweight | Get Alert | |
| 01/19/2023 | GILD | Buy Now | Gilead Sciences | $151.20 | -26.59% | $104 → $111 | Maintains | Overweight | Get Alert | |
| 01/19/2023 | CDXS | Buy Now | Codexis | $1.39 | 1554.68% | $22 → $23 | Maintains | Overweight | Get Alert | |
| 01/11/2023 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -19.42% | $38 → $42 | Maintains | Overweight | Get Alert | |
| 01/06/2023 | TCRR | Buy Now | TCR2 Therapeutics | — | — | $8 → $10 | Maintains | Overweight | Get Alert | |
| 12/12/2022 | AFMD | Buy Now | Affimed | — | — | $7 → $6 | Maintains | Overweight | Get Alert | |
| 10/28/2022 | GILD | Buy Now | Gilead Sciences | $151.20 | -36.51% | $79 → $96 | Upgrade | Neutral → Overweight | Get Alert | |
| 10/14/2022 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -27.1% | $39 → $38 | Maintains | Overweight | Get Alert | |
| 08/17/2022 | RIGL | Buy Now | Rigel Pharmaceuticals | $49.08 | -95.93% | $1 → $2 | Maintains | Neutral | Get Alert | |
| 08/17/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.08 | -43.54% | $256 → $288 | Maintains | Neutral | Get Alert | |
| 08/16/2022 | REPL | Buy Now | Replimune Group | $13.42 | 220.42% | $44 → $43 | Maintains | Overweight | Get Alert | |
| 07/26/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.08 | -49.81% | $242 → $256 | Maintains | Neutral | Get Alert | |
| 07/26/2022 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -21.34% | $40 → $41 | Maintains | Overweight | Get Alert | |
| 07/26/2022 | SDGR | Buy Now | Schrodinger | $27.24 | 215.7% | $84 → $86 | Maintains | Overweight | Get Alert | |
| 07/26/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $44.97 | 28.97% | $55 → $58 | Maintains | Overweight | Get Alert | |
| 07/26/2022 | GILD | Buy Now | Gilead Sciences | $151.20 | -53.04% | $69 → $71 | Maintains | Neutral | Get Alert | |
| 07/26/2022 | EXEL | Buy Now | Exelixis | $59.86 | -46.54% | $30 → $32 | Maintains | Overweight | Get Alert | |
| 07/26/2022 | ABCL | Buy Now | AbCellera Biologics | $12.54 | 75.43% | $21 → $22 | Maintains | Overweight | Get Alert | |
| 07/15/2022 | CDXS | Buy Now | Codexis | $1.39 | 1482.73% | $35 → $22 | Maintains | Overweight | Get Alert | |
| 06/23/2022 | SRRK | Buy Now | Scholar Rock Holding | $42.01 | -54.77% | $28 → $19 | Maintains | Overweight | Get Alert | |
| 05/17/2022 | SRRK | Buy Now | Scholar Rock Holding | $42.01 | -33.35% | $56 → $28 | Maintains | Overweight | Get Alert | |
| 05/17/2022 | GILD | Buy Now | Gilead Sciences | $151.20 | -54.37% | $73 → $69 | Maintains | Neutral | Get Alert | |
| 05/11/2022 | ABCL | Buy Now | AbCellera Biologics | $12.54 | 67.46% | $28 → $21 | Maintains | Overweight | Get Alert | |
| 05/06/2022 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -23.26% | $42 → $40 | Maintains | Overweight | Get Alert | |
| 05/06/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.08 | -52.56% | $249 → $242 | Maintains | Neutral | Get Alert | |
| 04/29/2022 | GILD | Buy Now | Gilead Sciences | $151.20 | -51.72% | $72 → $73 | Maintains | Neutral | Get Alert | |
| 04/22/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.08 | -51.18% | $245 → $249 | Maintains | Neutral | Get Alert | |
| 04/04/2022 | GILD | Buy Now | Gilead Sciences | $151.20 | -53.04% | $77 → $71 | Maintains | Neutral | Get Alert | |
| 03/31/2022 | TVTX | Buy Now | Travere Therapeutics | $52.13 | -19.42% | → $42 | Initiates | → Overweight | Get Alert | |
| 03/31/2022 | AFMD | Buy Now | Affimed | — | — | → $7 | Initiates | → Overweight | Get Alert | |
| 11/19/2021 | REPL | Buy Now | Replimune Group | $13.42 | 287.48% | → $52 | Initiates | → Overweight | Get Alert | |
| 11/19/2021 | SDGR | Buy Now | Schrodinger | $27.24 | 219.37% | → $87 | Initiates | → Overweight | Get Alert | |
| 11/19/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.08 | -57.26% | $323 → $218 | Downgrade | Overweight → Neutral | Get Alert | |
| 11/19/2021 | SRRK | Buy Now | Scholar Rock Holding | $42.01 | 33.3% | → $56 | Initiates | → Overweight | Get Alert | |
| 11/19/2021 | ABCL | Buy Now | AbCellera Biologics | $12.54 | 163.15% | → $33 | Initiates | → Overweight | Get Alert | |
| 05/03/2021 | MORF | Buy Now | Morphic Holding | — | — | $111 → $102 | Maintains | Outperform | Get Alert | |
| 03/23/2021 | IONS | Buy Now | Ionis Pharmaceuticals | $44.97 | 69% | $90 → $76 | Maintains | Outperform | Get Alert | |
| 03/08/2021 | NUVB | Buy Now | Nuvation Bio | $5.00 | 220% | → $16 | Initiates | → Outperform | Get Alert | |
| 02/02/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.08 | -44.32% | $302 → $284 | Maintains | Outperform | Get Alert | |
| 01/25/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $232.60 | -20.46% | → $185 | Downgrade | Outperform → Market Perform | Get Alert | |
| 01/25/2021 | CNST | Buy Now | Constellation | — | — | $27 → $50 | Upgrade | Market Perform → Outperform | Get Alert | |
| 01/05/2021 | ABCL | Buy Now | AbCellera Biologics | $12.54 | 282.77% | → $48 | Initiates | → Outperform | Get Alert | |
| 12/18/2020 | XCUR | Buy Now | Exicure | $1.01 | 494.06% | → $6 | Initiates | → Outperform | Get Alert | |
| 11/06/2020 | RTRX | Buy Now | Retrophin | — | — | $31 → $33 | Maintains | Outperform | Get Alert | |
| 09/01/2020 | AKCA | Buy Now | Akcea Therapeutics | — | — | $26 → $18.15 | Downgrade | Outperform → Market Perform | Get Alert | |
| 09/01/2020 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | → $32 | Initiates | → Outperform | Get Alert | |
| 08/06/2020 | CNST | Buy Now | Constellation | — | — | $34 → $28 | Maintains | Market Perform | Get Alert | |
| 07/07/2020 | OBSV | Buy Now | ObsEva | — | — | $5 → $4 | Downgrade | Outperform → Market Perform | Get Alert | |
| 06/15/2020 | CNST | Buy Now | Constellation | — | — | $42 → $34 | Maintains | Market Perform | Get Alert | |
| 05/14/2020 | SDGR | Buy Now | Schrodinger | $27.24 | 145.95% | $65 → $67 | Maintains | Outperform | Get Alert | |
| 05/12/2020 | HALO | Buy Now | Halozyme Therapeutics | $111.35 | -68.57% | $27 → $35 | Maintains | Outperform | Get Alert | |
| 05/12/2020 | RTRX | Buy Now | Retrophin | — | — | $33 → $34 | Maintains | Outperform | Get Alert | |
| 05/07/2020 | ALNY | Buy Now | Alnylam Pharmaceuticals | $232.60 | -26.48% | $145 → $171 | Maintains | Outperform | Get Alert | |
| 04/30/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $510.08 | -44.52% | $279 → $283 | Maintains | Outperform | Get Alert | |
| 03/02/2020 | SDGR | Buy Now | Schrodinger | $27.24 | 138.61% | → $65 | Initiates | → Outperform | Get Alert | |
| 02/27/2020 | IONS | Buy Now | Ionis Pharmaceuticals | $44.97 | 44.54% | $70 → $65 | Maintains | Neutral | Get Alert | |
| 01/09/2020 | HALO | Buy Now | Halozyme Therapeutics | $111.35 | -78.45% | $17 → $24 | Upgrade | Market Perform → Outperform | Get Alert | |
| 11/25/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $232.60 | -38.52% | $138 → $143 | Maintains | Outperform | Get Alert | |
| 11/21/2019 | ALNY | Buy Now | Alnylam Pharmaceuticals | $232.60 | -40.67% | $128 → $138 | Maintains | Outperform | Get Alert | |
| 11/13/2019 | MORF | Buy Now | Morphic Holding | — | — | $32 → $30 | Maintains | Outperform | Get Alert | |
| 11/13/2019 | HALO | Buy Now | Halozyme Therapeutics | $111.35 | -84.73% | $16 → $17 | Maintains | Market Perform | Get Alert | |
| 11/07/2019 | CNST | Buy Now | Constellation | — | — | $17 → $43 | Maintains | Outperform | Get Alert | |
| 11/07/2019 | IONS | Buy Now | Ionis Pharmaceuticals | $44.97 | 55.66% | $75 → $70 | Maintains | Neutral | Get Alert | |
| 11/06/2019 | AKCA | Buy Now | Akcea Therapeutics | — | — | $39 → $36 | Maintains | Outperform | Get Alert | |
| 10/08/2019 | AKCA | Buy Now | Akcea Therapeutics | — | — | $43 → $39 | Maintains | Outperform | Get Alert | |
| 08/23/2019 | RTRX | Buy Now | Retrophin | — | — | $38 → $33 | Maintains | Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved